Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Inv. presentation
Quarterly results
|
|
Sonnet BioTherapeutics Holdings, Inc. (BURG)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/31/2023 |
4
| Dyrness Albert D. (Director) has filed a Form 4 on Sonnet BioTherapeutics Holdings, Inc.|
Txns:
| Bought 23,255 shares
@ $0.468, valued at
$10.9k
|
|
| 05/18/2023 |
4
| Bhatt Nailesh (Director) has filed a Form 4 on Sonnet BioTherapeutics Holdings, Inc.|
Txns:
| Bought 25,000 shares
@ $0.232, valued at
$5.8k
|
|
| 05/15/2023 |
4
| Mohan Pankaj (Chairman, President and CEO) has filed a Form 4 on Sonnet BioTherapeutics Holdings, Inc.|
Txns:
| Bought 371,600 shares
@ $0.223, valued at
$82.9k
|
|
| 03/16/2023 |
4
| Mohan Pankaj (Chairman, President and CEO) has filed a Form 4 on Sonnet BioTherapeutics Holdings, Inc.|
Txns:
| Bought 60,000 shares
@ $0.585, valued at
$35.1k
|
|
| 12/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/08/2022 |
4
| Dexter Susan (Chief Technical Officer) has filed a Form 4 on Sonnet BioTherapeutics Holdings, Inc.|
Txns:
| Granted 63,104 shares
@ $0 |
|
| 04/08/2022 |
4
| Rao Raghu (Director) has filed a Form 4 on Sonnet BioTherapeutics Holdings, Inc.|
Txns:
| Granted 14,152 shares
@ $0 |
|
| 04/08/2022 |
4
| Cini John K. (Chief Scientific Officer) has filed a Form 4 on Sonnet BioTherapeutics Holdings, Inc.|
Txns:
| Granted 80,034 shares
@ $0 |
|
| 04/08/2022 |
4
| Mohan Pankaj (Chairman, President and CEO) has filed a Form 4 on Sonnet BioTherapeutics Holdings, Inc.|
Txns:
| Granted 320,135 shares
@ $0 |
|
| 04/08/2022 |
4
| Cross John Harry III (CFO) has filed a Form 4 on Sonnet BioTherapeutics Holdings, Inc.|
Txns:
| Granted 66,951 shares
@ $0 |
|
| 04/08/2022 |
4
| Dyrness Albert D. (Director) has filed a Form 4 on Sonnet BioTherapeutics Holdings, Inc.|
Txns:
| Granted 14,152 shares
@ $0 |
|
| 04/08/2022 |
4
| Bhatt Nailesh (Director) has filed a Form 4 on Sonnet BioTherapeutics Holdings, Inc.|
Txns:
| Granted 14,152 shares
@ $0 |
|
| 06/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2021 |
4
| Mohan Pankaj (Chairman, President and CEO) has filed a Form 4 on Sonnet BioTherapeutics Holdings, Inc.|
Txns:
| Bought 4,000 shares
@ $1.545, valued at
$6.2k
Bought 28,000 shares
@ $1.55, valued at
$43.4k
|
|
| 05/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2021 |
4
| Griffith Donald J. (Director) has filed a Form 4 on Sonnet BioTherapeutics Holdings, Inc.|
Txns:
| Paid exercise price by delivering 4,235 shares
@ $1.51, valued at
$6.4k
|
|
| 05/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Rao Raghu (Director) has filed a Form 4 on Sonnet BioTherapeutics Holdings, Inc.|
Txns:
| Granted 8,005 shares
@ $0 |
|
| 07/02/2020 |
4
| RUGG TERENCE ANTHONY (Chief Medical Officer) has filed a Form 4 on Sonnet BioTherapeutics Holdings, Inc.|
Txns:
| Granted 21,314 shares
@ $0 |
|
| 07/02/2020 |
4
| Mohan Pankaj (Chairman, President and CEO) has filed a Form 4 on Sonnet BioTherapeutics Holdings, Inc.|
Txns:
| Granted 319,866 shares
@ $0 |
|
| 07/02/2020 |
4
| Dexter Susan (Chief Technical Officer) has filed a Form 4 on Sonnet BioTherapeutics Holdings, Inc.|
Txns:
| Granted 73,613 shares
@ $0 |
|
| 07/02/2020 |
4
| Cini John K. (Chief Scientific Officer) has filed a Form 4 on Sonnet BioTherapeutics Holdings, Inc.|
Txns:
| Granted 78,214 shares
@ $0 |
|
| 07/02/2020 |
4
| Griffith Donald J. (Director) has filed a Form 4 on Sonnet BioTherapeutics Holdings, Inc.|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 07/02/2020 |
4
| Cross John Harry III (CFO) has filed a Form 4 on Sonnet BioTherapeutics Holdings, Inc.|
Txns:
| Granted 78,214 shares
@ $0 |
|
|
|
|